Advertisement

Elevated basal progesterone levels are associated with increased preovulatory progesterone rise but not with higher pregnancy rates in ICSI cycles with GnRH antagonists

      Abstract

      Objective

      To ascertain the association between basal progesterone (P) levels and the occurrence of preovulatory progesterone rise (PPR) and clinical pregnancy rates (CPRs) in ICSI cycles with GnRH antagonists.

      Study design

      Serum P levels of 464 patients were measured on day 2 and day of hCG of cycles. Cycles with basal P levels > 1.6 ng/mL were cancelled. All embryos were cryopreserved in cycles with P levels ≥ 2 ng/mL on the day of hCG. The primary outcome measures were the incidence of PPR (P > 1.5 ng/mL) and CPR with regard to basal P.

      Results

      Basal P levels were significantly higher in cycles with PPR than in those without PPR (0.63 ± 0.31 vs. 0.48 ± 0.28 ng/mL). Area under the curve for basal P according to ROC analysis to discriminate between elevated and normal P levels on the day of hCG was 0.65 (0.58–0.71 95% CI, p < 0.01). The cut-off value for basal P levels that best discriminates between cycles with and without PPR was 0.65 ng/mL. Cycles with basal P levels above 0.65 ng/mL had a significantly higher incidence of PPR (30.9% vs. 13.5%) but similar clinical and cumulative pregnancy rates (38.8% vs. 31.1% and 41.7% vs. 32.6%, respectively) in comparison to cycles with basal P levels below 0.65 ng/mL. In multivariate regression analysis, basal P levels, LH level on the first day of antagonist administration, and estradiol levels on the day of hCG trigger were the variables that predicted PPR.

      Conclusion

      Basal P levels were associated with increased incidence of PPR but not with CPR.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Smitz J.
        • Ron-El R.
        • Tarlatzis B.C.
        The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: experience from three centres.
        Hum Reprod. 1992; 7: 49-66
        • Huang J.C.
        • Jackson K.V.
        • Hornstein M.D.
        • Ginsburg E.S.
        The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.
        J Assist Reprod Genet. 1996; 13: 617-624
        • Kolibianakis E.M.
        • Zikopoulos K.
        • Smitz J.
        • Camus M.
        • Tournaye H.
        • Van Steirteghem A.C.
        • et al.
        Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists.
        Hum Reprod. 2004; 19: 1525-1529
        • Bosch E.
        • Labarta E.
        • Crespo J.
        • Simon C.
        • Remohi J.
        • Jenkins J.
        • et al.
        Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles.
        Hum Reprod. 2010; 25: 2092-2100
        • Fanchin R.
        • de Ziegler D.
        • Taieb J.
        • Hazout A.
        • Frydman R.
        Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer.
        Fertil Steril. 1993; 59: 1090-1094
        • Shulman A.
        • Ghetler Y.
        • Beyth Y.
        • Ben-Nun I.
        The significance of an early (premature) rise of plasma progesterone in in vitro fertilization cycles induced by a long protocol of gonadotropin releasing hormone analogue and human menopausal gonadotropins.
        J Assist Reprod Genet. 1996; 13: 207-211
        • Bustillo M.
        • Stern J.J.
        • Coulam C.B.
        Serum progesterone at the time of human chorionic gonadotrophin does not predict pregnancy in in-vitro fertilization and embryo transfer.
        Hum Reprod. 1995; 10: 2862-2867
        • Hofmann G.E.
        • Bentzien F.
        • Bergh P.A.
        • Garrisi G.J.
        • Williams M.C.
        • Guzman I.
        • et al.
        Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality.
        Fertil Steril. 1993; 60: 675-679
        • Xu B.
        • Li Z.
        • Zhang H.
        • Jin L.
        • Li Y.
        • Ai J.
        • et al.
        Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles.
        Fertil Steril. 2012; 97 (e1321–1324): 1321-1327
        • Fanchin R.
        • Hourvitz A.
        • Olivennes F.
        • Taieb J.
        • Hazout A.
        • Frydman R.
        Premature progesterone elevation spares blastulation but not pregnancy rates in in vitro fertilization with coculture.
        Fertil Steril. 1997; 68: 648-652
        • Hamdine O.
        • Macklon N.S.
        • Eijkemans M.J.
        • Laven J.S.
        • Cohlen B.J.
        • Verhoeff A.
        • et al.
        Elevated early follicular progesterone levels and in vitro fertilization outcomes: a prospective intervention study and meta-analysis.
        Fertil Steril. 2014; 102 (e441): 448-454
        • Blockeel C.
        • Baumgarten M.
        • De Vos M.
        • Verheyen G.
        • Devroey P.
        Administration of GnRH antagonists in case of elevated progesterone at initiation of the cycle: a prospective cohort study.
        Curr Pharm Biotechnol. 2011; 12: 423-428
        • Venetis C.A.
        • Kolibianakis E.M.
        • Bosdou J.K.
        • Lainas G.T.
        • Sfontouris I.A.
        • Tarlatzis B.C.
        • et al.
        Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
        Hum Reprod. 2016;
        • Keltz M.D.
        • Stein D.E.
        • Berin I.
        • Skorupski J.
        Elevated progesterone-to-estradiol ratio versus serum progesterone alone for predicting poor cycle outcome with in vitro fertilization.
        J Reprod Med. 2012; 57: 9-12
        • Kyrou D.
        • Al-Azemi M.
        • Papanikolaou E.G.
        • Donoso P.
        • Tziomalos K.
        • Devroey P.
        • et al.
        The relationship of premature progesterone rise with serum estradiol levels and number of follicles in GnRH antagonist/recombinant FSH-stimulated cycles.
        Eur J Obstet Gynecol Reprod Biol. 2012; 162: 165-168
        • Venetis C.A.
        • Kolibianakis E.M.
        • Bosdou J.K.
        • Tarlatzis B.C.
        Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles.
        Hum Reprod Update. 2013; 19: 433-457
        • Edelstein M.C.
        • Seltman H.J.
        • Cox B.J.
        • Robinson S.M.
        • Shaw R.A.
        • Muasher S.J.
        Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome.
        Fertil Steril. 1990; 54: 853-857
        • Silverberg K.M.
        • Burns W.N.
        • Olive D.L.
        • Riehl R.M.
        • Schenken R.S.
        Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins.
        J Clin Endocrinol Metab. 1991; 73: 797-803
        • Check J.H.
        Predictive value of serum progesterone levels for pregnancy outcome.
        Fertil Steril. 1994; 62: 1090-1091
        • Givens C.R.
        • Schriock E.D.
        • Dandekar P.V.
        • Martin M.C.
        Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles.
        Fertil Steril. 1994; 62: 1011-1017
        • Levy M.J.
        • Smotrich D.B.
        • Widra E.A.
        • Sagoskin A.W.
        • Murray D.L.
        • Hall J.L.
        The predictive value of serum progesterone and 17-OH progesterone levels on in vitro fertilization outcome.
        J Assist Reprod Genet. 1995; 12: 161-166
        • Abuzeid M.I.
        • Sasy M.A.
        Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transfer.
        Fertil Steril. 1996; 65: 981-985
        • Hofmann G.E.
        • Khoury J.
        • Johnson C.A.
        • Thie J.
        • Scott Jr., R.T.
        Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact on pregnancy outcome.
        Fertil Steril. 1996; 66: 980-986
        • Miller K.F.
        • Behnke E.J.
        • Arciaga R.L.
        • Goldberg J.M.
        • Chin N.W.
        • Awadalla S.G.
        The significance of elevated progesterone at the time of administration of human chorionic gonadotropin may be related to luteal support.
        J Assist Reprod Genet. 1996; 13: 698-701
        • Moffitt D.V.
        • Queenan Jr., J.T.
        • Shaw R.
        • Muasher S.J.
        Progesterone levels on the day of human chorionic gonadotropin do not predict pregnancy outcome from the transfer of fresh or cryopreserved embryos from the same cohort.
        Fertil Steril. 1997; 67: 296-301
        • Doldi N.
        • Marsiglio E.
        • Destefani A.
        • Gessi A.
        • Merati G.
        • Ferrari A.
        Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome.
        Hum Reprod. 1999; 14: 601-605
        • Urman B.
        • Alatas C.
        • Aksoy S.
        • Mercan R.
        • Isiklar A.
        • Balaban B.
        Elevated serum progesterone level on the day of human chorionic gonadotropin administration does not adversely affect implantation rates after intracytoplasmic sperm injection and embryo transfer.
        Fertil Steril. 1999; 72: 975-979
        • Martinez F.
        • Coroleu B.
        • Clua E.
        • Tur R.
        • Buxaderas R.
        • Parera N.
        • et al.
        Serum progesterone concentrations on the day of HCG administration cannot predict pregnancy in assisted reproduction cycles.
        Reprod Biomed Online. 2004; 8: 183-190
        • Bosch E.
        • Valencia I.
        • Escudero E.
        • Crespo J.
        • Simon C.
        • Remohi J.
        • et al.
        Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome.
        Fertil Steril. 2003; 80: 1444-1449
        • Azem F.
        • Tal G.
        • Lessing J.B.
        • Malcov M.
        • Ben-Yosef D.
        • Almog B.
        • et al.
        Does high serum progesterone level on the day of human chorionic gonadotropin administration affect pregnancy rate after intracytoplasmic sperm injection and embryo transfer.
        Gynecol Endocrinol. 2008; 24: 368-372
        • Check J.H.
        • Lurie D.
        • Askari H.A.
        • Hoover L.
        • Lauer C.
        The range of subtle rise in serum progesterone levels following controlled ovarian hyperstimulation associated with lower in vitro fertilization pregnancy rates is determined by the source of manufacturer.
        Eur J Obstet Gynecol Reprod Biol. 1993; 52: 205-209
        • Harada T.
        • Yoshida S.
        • Katagiri C.
        • Takao N.
        • Ikenari T.
        • Toda T.
        • et al.
        Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a gonadotrophin-releasing hormone agonist and gonadotrophin.
        Hum Reprod. 1995; 10: 1060-1064
        • Ubaldi F.
        • Smitz J.
        • Wisanto A.
        • Joris H.
        • Schiettecatte J.
        • Derde M.P.
        • et al.
        Oocyte and embryo quality as well as pregnancy rate in intracytoplasmic sperm injection are not affected by high follicular phase serum progesterone.
        Hum Reprod. 1995; 10: 3091-3096
        • Kyrou D.
        • Popovic-Todorovic B.
        • Fatemi H.M.
        • Bourgain C.
        • Haentjens P.
        • Van Landuyt L.
        • et al.
        Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist?.
        Hum Reprod. 2009; 24: 2902-2909
        • Fleming R.
        • Jenkins J.
        The source and implications of progesterone rise during the follicular phase of assisted reproduction cycles.
        Reprod Biomed Online. 2010; 21: 446-449
        • Kolibianakis E.M.
        • Bourgain C.
        • Papanikolaou E.G.
        • Camus M.
        • Tournaye H.
        • Van Steirteghem A.C.
        • et al.
        Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles.
        Hum Reprod. 2005; 20: 2453-2456
        • Eldar-Geva T.
        • Margalioth E.J.
        • Brooks B.
        • Algur N.
        • Zylber-Haran E.
        • Diamant Y.Z.
        The origin of serum progesterone during the follicular phase of menotropin-stimulated cycles.
        Hum Reprod. 1998; 13: 9-14
        • De Geyter C.
        • De Geyter M.
        • Huber P.R.
        • Nieschlag E.
        • Holzgreve W.
        Progesterone serum levels during the follicular phase of the menstrual cycle originate from the crosstalk between the ovaries and the adrenal cortex.
        Hum Reprod. 2002; 17: 933-939
        • Judd S.
        • Terry A.
        • Petrucco M.
        • White G.
        The source of pulsatile secretion of progesterone during the human follicular phase.
        J Clin Endocrinol Metab. 1992; 74: 299-305